- Home
- MODD vs ECOR Comparison
MODD vs ECOR Comparison
Compare MODD & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODD
- ECOR
- Stock Information
- Founded
- MODD 1998
- ECOR 2005
- Country
- MODD United States
- ECOR United States
- Employees
- MODD N/A
- ECOR N/A
- Industry
- MODD Industrial Specialties
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MODD Health Care
- ECOR Health Care
- Exchange
- MODD Nasdaq
- ECOR Nasdaq
- Market Cap
- MODD 67.4M
- ECOR 65.0M
- IPO Year
- MODD N/A
- ECOR 2018
- Fundamental
- Price
- MODD $1.55
- ECOR $17.30
- Analyst Decision
- MODD Buy
- ECOR Strong Buy
- Analyst Count
- MODD 1
- ECOR 1
- Target Price
- MODD $5.00
- ECOR $15.00
- AVG Volume (30 Days)
- MODD 235.8K
- ECOR 97.7K
- Earning Date
- MODD 02-11-2025
- ECOR 11-13-2024
- Dividend Yield
- MODD N/A
- ECOR N/A
- EPS Growth
- MODD N/A
- ECOR N/A
- EPS
- MODD N/A
- ECOR N/A
- Revenue
- MODD N/A
- ECOR $23,327,000.00
- Revenue This Year
- MODD N/A
- ECOR $61.40
- Revenue Next Year
- MODD $830.43
- ECOR $38.43
- P/E Ratio
- MODD N/A
- ECOR N/A
- Revenue Growth
- MODD N/A
- ECOR 74.10
- 52 Week Low
- MODD $1.08
- ECOR $5.25
- 52 Week High
- MODD $2.65
- ECOR $15.25
- Technical
- Relative Strength Index (RSI)
- MODD 27.32
- ECOR 69.93
- Support Level
- MODD $1.45
- ECOR $13.22
- Resistance Level
- MODD $1.71
- ECOR $14.87
- Average True Range (ATR)
- MODD 0.09
- ECOR 1.34
- MACD
- MODD -0.00
- ECOR 0.30
- Stochastic Oscillator
- MODD 29.24
- ECOR 87.04
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.